Avacta Group Plc AVCTF
Set alert
At close · Oct 30
- YTD
- +9.27%
- 1 year
- -19.05%
- Open
- 0.9598
- Prev close
- 0.85
- Mkt cap
- 371.99M
- Vol
- 400
- Avg vol
- 695
- EPS
- -0.12
- P/E
- 0.00
More statistics
- Low
- 0.9598
- High
- 0.9598
News
2 weeks ago seekingalpha.com
Avacta Group Plc (AVCTF) Q2 2026 Earnings Call Transcript
Avacta Group Plc (AVCTF) Q2 2026 Earnings Call Transcript
2 weeks ago defenseworld.net
Avacta Group Plc (OTCMKTS:AVCTF) Stock Short Interest Report for September
Avacta Group Plc (OTCMKTS:AVCTF - Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totaling 10 shares. Based on…
3 months ago globenewswire.com
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
LONDON and PHILADELPHIA, July 08, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a…
5 months ago globenewswire.com
Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026
Multiple confirmed partial and minor responses observed in patients with SGC Continuing very good safety profile, with removal of the lifetime maximum doxorubicin limit based on highly favorable…
5 months ago seekingalpha.com
Avacta Group Plc (AVCTF) Q4 2025 Earnings Call Transcript
Avacta Group Plc (AVCTF) Q4 2025 Earnings Call Transcript
5 months ago globenewswire.com
Unaudited Preliminary Results for the Year Ended December 31, 2025
LONDON and PHILADELPHIA, May 19, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated…
5 months ago globenewswire.com
Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026
LONDON and PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a…
10 months ago defenseworld.net
Avacta Group (OTCMKTS:AVCTF) Stock Price Down 5.3% – Here’s What Happened
Avacta Group Plc (OTCMKTS:AVCTF - Get Free Report) shares dropped 5.3% on Friday. The company traded as low as $0.8151 and last traded at $0.8151. Approximately 4,000 shares were traded during…
10 months ago seekingalpha.com
Avacta Group Plc (AVCTF) Discusses Initial Faridoxorubicin Phase Ib Data and Safety Profile in Salivary Gland Cancer Transcript
Avacta Group Plc (AVCTF) Discusses Initial Faridoxorubicin Phase Ib Data and Safety Profile in Salivary Gland Cancer Transcript
11 months ago defenseworld.net
Avacta Group (OTCMKTS:AVCTF) Trading 1.2% Higher – What’s Next?
Avacta Group Plc (OTCMKTS:AVCTF - Get Free Report) shares were up 1.2% during mid-day trading on Thursday. The stock traded as high as $0.98 and last traded at $0.98. Approximately 200 shares changed…
12 months ago defenseworld.net
Short Interest in Avacta Group Plc (OTCMKTS:AVCTF) Rises By 61.6%
Avacta Group Plc (OTCMKTS:AVCTF - Get Free Report) was the target of a large increase in short interest in October. As of October 15th, there was short interest totaling 89,200 shares, an increase of…
1 year ago seekingalpha.com
Avacta Group Plc (AVCTF) Q2 2025 Earnings Call Transcript
Avacta Group Plc (OTCPK:AVCTF) Q2 2025 Earnings Call September 30, 2025 9:00 AM EDT Company Participants Christina Coughlin - CEO & Executive Director Brian Hahn - CFO & Company Secretary…
1 year ago globenewswire.com
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development
LONDON and PHILADELPHIA, July 01, 2025 (GLOBE NEWSWIRE) -- Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the appointment of…
1 year ago seekingalpha.com
Avacta Group Plc (AVCTF) Preliminary Q4 2024 Earnings Conference Call Transcript
Avacta Group Plc Q2 2025 Earnings Conference Call June 6, 2025 6:00 AM ET Company Participants Brian M. Hahn - Chief Financial Officer Christina Marie Coughlin - CEO, Interim Chief Medical Officer…
2 years ago seekingalpha.com
Avacta Group Plc (AVCTF) Q2 2024 Earnings Call Transcript
Avacta Group Plc (OTCPK:AVCTF) Q2 2024 Earnings Conference Call September 30, 2024 6:00 AM ET Company Participants Christina Coughlin - Chief Executive Officer Conference Call Participants Operator…
2 years ago seekingalpha.com
Avacta Group PLC (AVCTF) Q4 2023 Earnings Call Transcript
Avacta Group PLC (OTCPK:AVCTF) Q4 2023 Earnings Conference Call April 30, 2024 7:30 AM ET Company Participants Christina Coughlin - CEO Tony Gardiner - CFO Conference Call Participants Operator Good…